Assessment of Dapagliflozin Effectiveness as Add-on Therapy for the Treatment of Type 2 Diabetes Mellitus . (2022). Academia Journal of Medicine, 4(2), 50-54. https://medjournal.co.in/index.php/ajm/article/view/82